Newsstand
The global biosimilars market is expected to reach $6.22 Billion 1 Click to read
  • Comments

The global biosimilars market is expected to reach $6.22 Billion

1

Published on in “Health & Fitness”, language — English. 3 pages.
Biosimilars Market categories the Global Market by Application (Oncology, Blood Disorders), Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Mono More
Show Tags
Tags: biosimilars market · insulin market · filgrastim market
Subscribe for FREE

Related Magazines